Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks524703-BOM
resources
524703-BOM

Sandu Pharmaceuticals Ltd.

BSE: 524703
Sector: Healthcare
Industry: Pharmaceuticals
39.30+0.0 (+0.03%)
27 Jul, 3:29 PM

Annual Reports and Financial Documents

Sandu Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results————————————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Sandu Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General11 Jul 2026
    Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders
    Reconstitution of Committees of Board-Audit/Nomination/Stakeholders
  • Change in Directorate11 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company 2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman ....
  • Outcome of Board Meeting11 Jul 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026
    Outcome of the Board Meeting dated 11.07.2026
  • Newspaper Publication8 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    newspaper publication-opening of special window for relodgment of special window for transfer of shares and second 100 days campaign saksham niveshak
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI(DP) Regulation
  • Board Meeting6 Jul 2026
    Board Meeting Intimation for To Place On Record The Demise Of Shri Umesh B. Sandu(DIN:01132141), Managing Director Of The Company, On 19Th June, 2026, And To Record The Board''s Appreciation For His Invaluable Contribution To The Company.
    Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve 1. To place on record ....
  • Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    intimation about closure of trading window for q ended 30th June 2026
  • General20 Jun 2026
    Announcement Under Regulation 30
    demise of Shri Umesh Sandu, Managing Director (DIN:01132141) revised disclosure
  • Change in Directorate19 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Sad demise of Shri Umesh Sandu (DIN:01132141) Managing Director of the company
  • Cessation19 Jun 2026
    Announcement under Regulation 30 (LODR)-Cessation
    sad demise of Shri Umesh Sandu as Managing Director(DIN:01132141)
  • Demise19 Jun 2026
    Announcement under Regulation 30 (LODR)-Demise
    Intimation about sad demise of our Managing Director ,Shri Umesh Sandu(DIN:01132141)
  • Newspaper Publication6 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for opening of special window for re lodgment of transfer requests for physical shares and Second 100 days campaign Saksham Niveshak creating awareness amongst ....
  • Reg.24(A)-Annual Secretarial Compliance18 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for Year ended 31st March 2026
  • General7 May 2026
    Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner, Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT, Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As Per Physical Verification Of Goods.
    Demand order from office of assistant commissioner, due to discrepancy in quantity as per invoice and quantity as per physical verification of Goods
  • Newspaper Publication7 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for Audited Financials for the Q and Year ended 31.03.2026
  • Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B25 May 2026
    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
    <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
  • Reg. 32 (1), (3) - Statement of Deviation & Variation5 May 2026
    Statement Of Deviation And Variation Of Funds For Q Ended 31.03.2026
    Statement of Deviation and Variation of Funds for q ended 31.03.2026
  • Change in Management5 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Re-appointment of Internal Auditors and Cost Auditor for the FY 2026-27
  • Dividend5 May 2026
    Corporate Action-Board approves Dividend
    Board Approves Final Dividend for the FY 2025-26
  • Outcome of Board Meeting5 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Dated 05Th May 2026
    Outcome of the Board Meeting dated 05th May 2026

Frequently Asked Questions

Where can I download the annual report of Sandu Pharmaceuticals Ltd.?
Annual reports of Sandu Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Sandu Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Sandu Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Sandu Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Sandu Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Sandu Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Sandu Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Sandu Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Sandu Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Sandu Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sandu Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Sandu Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Sandu Pharmaceuticals Ltd. is INE751D01014. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Sandu Pharmaceuticals Ltd. listed?
Sandu Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 524703-BOM and the BSE code is -.
Where can I find the shareholding pattern of Sandu Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Sandu Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Sandu Pharmaceuticals Ltd. on Sharpely?
Share price data for Sandu Pharmaceuticals Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.